phosphatide/悪性腫瘍

INTRODUCTION The present invention concerns new Esters and Phosphatides with Vitamin-D and Vitamin-E compounds, processes for their production as well as for the preparation of spontaneously dispersible concentrates and pharmaceutical compositions containing these compounds, and their use for the

The present invention relates to aerosol compositions containing a carrier agent capable agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate. More especially, the present invention relates to aerosol

INTRODUCTION The present invention concerns new Esters and Phosphatides with Vitamin-D and Vitamin-E compounds, processes for their production as well as for the preparation of spontaneously dispersible concentrates and pharmaceutical compositions containing these compounds, and their use for the

INTRODUCTION 1. Technical Field The field of this invention concerns the treatment of rapidly proliferating cells, particularly neoplastic cells, to diminish the rate of proliferation. The methods employ drugs which act a mitotic inhibitors. 2. Background Despite the long history of efforts to treat

This invention relates to pharmaceutically-acceptable compositions, and more particularly to injectable compositions comprising ether phospholipid or carbamoyl salts and triglyceride-water emulsions as well as the use thereof. Certain ether phospholipid and carbamoyl salts are useful as platelet